Non-Alcoholic Fatty Liver Diseases
The term "non-alcoholic fatty liver disease" (NAFLD) or "metabolic (dysfunction) associated fatty liver disease" (MAFLD) refers to an abnormal accumulation of fat in the liver that has no other obvious cause, such as alcohol consumption. There are 2 types: non-alcoholic steatohepatitis (NASH), which also causes liver inflammation, and non-alcoholic fatty liver (NAFL). Non-alcoholic fatty liver usually does not proceed to NASH and is less harmful than NASH. When NAFL eventually transforms into NASH, it may also bring on side effects like cirrhosis, liver cancer, liver failure, or cardiovascular disease.
Obesity and type 2 diabetes are strong risk factors for NAFLD. Other risks include being overweight, metabolic syndrome (defined as at least three of the five following medical conditions: abdominal obesity, high blood pressure, high blood sugar, high serum triglycerides, and low serum HDL cholesterol), a diet high in fructose, and older age. NAFLD and alcoholic liver disease are types of fatty liver disease. Obtaining a sample of the liver after excluding other potential causes of fatty liver can confirm the diagnosis.
Related Conference of Non-Alcoholic Fatty Liver Diseases
18th World Conference on Gynecology, Obstetrics and Women Health
26th International Conference on Gastroenterology and Hepatology
25th International Conference on Gastroenterology and Digestive Disorders
Non-Alcoholic Fatty Liver Diseases Conference Speakers
Recommended Sessions
Related Journals
Are you interested in
- Abdominal & Primary Care - Gastro Congress 2026 (UK)
- Adolescent Gynecology and Reproductive Development - Gynecology2026 (Spain)
- Advances in Assisted Reproductive Technologies - Gynecology2026 (Spain)
- Advances in Maternal-Fetal Medicine - Gynecology2026 (Spain)
- Advances in Medical Imaging - Gastrosummit 2027 (France)
- Advances in Neonatal and Perinatal Medicine - Gynecology2026 (Spain)
- Advances in Obstetric and Gynecologic Imaging - Gynecology2026 (Spain)
- Advances in Prenatal and Postnatal Care - Gynecology2026 (Spain)
- Artificial Intelligence and Digital Transformation in Women’s Healthcare - Gynecology2026 (Spain)
- Celiac Disease - Gastrosummit 2027 (France)
- Celiac Diseases - Gastro Congress 2026 (UK)
- Colorectal Diseases - Gastrosummit 2027 (France)
- Contraceptive Technologies and Family Planning - Gynecology2026 (Spain)
- Covid-19 effects on gastroenterology practices - Gastro Congress 2026 (UK)
- Digestive System Cancers - Gastrosummit 2027 (France)
- Endometriosis and Pelvic Pain Management - Gynecology2026 (Spain)
- Esophageal and Gastric Disease - Gastro Congress 2026 (UK)
- Esophageal Disorders - Gastrosummit 2027 (France)
- Esophageal Disorders - Gastrosummit 2027 (France)
- Future Trends in Gynecology and Women’s Health Research - Gynecology2026 (Spain)
- Gastric Diseases and Peptic Ulcers - Gastrosummit 2027 (France)
- Gastric Diseases and Peptic Ulcers - Gastrosummit 2027 (France)
- Gastroenterology - Gastro Congress 2026 (UK)
- Gastrointestinal Bleeding - Gastrosummit 2027 (France)
- Gastrointestinal Cancer - Gastro Congress 2026 (UK)
- Gastrointestinal Endoscopy and Surgery - Gastro Congress 2026 (UK)
- Gastrointestinal Pathology - Gastro Congress 2026 (UK)
- Gastrointestinal Pharmacology - Gastrosummit 2027 (France)
- Gastrointestinal Pharmacotherapy - Gastro Congress 2026 (UK)
- Gastrointestinal Surgery - Gastrosummit 2027 (France)
- Genetics and Reproductive Medicine - Gynecology2026 (Spain)
- Geriatric Gastroenterology - Gastrosummit 2027 (France)
- Global Women’s Health and Reproductive Rights - Gynecology2026 (Spain)
- Gynecologic Oncology and Cancer Prevention - Gynecology2026 (Spain)
- Hepatitis - Gastro Congress 2026 (UK)
- Hepatology - Gastro Congress 2026 (UK)
- Inflammatory Bowel Disease (IBD) - Gastrosummit 2027 (France)
- Innovations in Gynecologic and Obstetric Pharmacology - Gynecology2026 (Spain)
- Innovations in Midwifery and Safe Childbirth Practices - Gynecology2026 (Spain)
- Liver Diseases and Hepatology - Gastrosummit 2027 (France)
- Liver Transplantation - Gastrosummit 2027 (France)
- Maternal Mental Health and Postpartum Wellbeing - Gynecology2026 (Spain)
- Maternal Nutrition and Lactation Science - Gynecology2026 (Spain)
- Menopause and Healthy Aging in Women - Gynecology2026 (Spain)
- Menstrual Health and Disorders - Gynecology2026 (Spain)
- Microbiota - Gastro Congress 2026 (UK)
- Minimally Invasive Gynecologic Surgery - Gynecology2026 (Spain)
- Nutrition in Digestive Health - Gastrosummit 2027 (France)
- Paediatric Gastroenterology - Gastro Congress 2026 (UK)
- Pancreatic and biliary disease - Gastro Congress 2026 (UK)
- Pancreatic Diseases - Gastrosummit 2027 (France)
- Pancreaticobiliary Disorders - Gastrosummit 2027 (France)
- Pediatric Gastroenterology - Gastrosummit 2027 (France)
- Polycystic Ovary Syndrome and Hormonal Disorders - Gynecology2026 (Spain)
- Precision Medicine in Digestive Diseases - Gastrosummit 2027 (France)
- Preventive Gynecology and Public Health - Gynecology2026 (Spain)
- Reproductive Endocrinology and Infertility - Gynecology2026 (Spain)
- Sexual and Reproductive Health Education - Gynecology2026 (Spain)
- Small Bowel and Colonic Disease - Gastro Congress 2026 (UK)
- Urogynecology and Pelvic Floor Disorders - Gynecology2026 (Spain)
- Viral Hepatitis - Gastrosummit 2027 (France)

